Y-Intercept (HK)
ETON icon

Y-Intercept (HK)’s Eton Pharmaceutcials ETON Stock Holding History

Y-Intercept (HK)’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$784K Sell
15,230
-18,312
-55% -$929K 0.02% 1111
2026
Q2 		$1.21M Buy
+33,542
New +$984K 0.02% 959
2025
Q3 		– Sell
-10,991
Closed -$157K – 1698
2025
Q2 		$157K Sell
10,991
-2,409
-18% -$38.1K ﹤0.01% 1492
2025
Q1 		$174K Buy
+13,400
New +$202K 0.01% 1074
2024
Q1 		– Sell
-10,688
Closed -$46.8K – 1477
2023
Q4 		$46.8K Buy
+10,688
New +$42.8K ﹤0.01% 1164

Other funds holding ETON

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
BankChampaign National Association
BankChampaign National Association Champaign, Illinois $120M AUM 54.13% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
Kings Path Partners
Kings Path Partners Sugar Land, Texas $380M AUM 12.42% 1-Year Est. Return

Y-Intercept (HK)'s ETON Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Eton Pharmaceutcials (ETON) stake by 55% in Q3 2026, selling an estimated $929K and leaving 15,230 shares worth $784K. The position accounts for 0.02% of the portfolio, ranked #1111.

Y-Intercept (HK) first reported a position in ETON in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.21M in Q2 2026. 31 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Y-Intercept (HK) held 15,230 shares of Eton Pharmaceutcials worth $784K as of Q3 2026.
  • Y-Intercept (HK) sold 18,312 Eton Pharmaceutcials shares in Q3 2026, an estimated $929K.
  • Eton Pharmaceutcials made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1111 holding.
  • Y-Intercept (HK) first reported a position in Eton Pharmaceutcials in Q4 2023 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Eton Pharmaceutcials position peaked at $1.21M in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.